Filing Details

Accession Number:
0001415889-23-014511
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-24 21:45:16
Reporting Period:
2023-10-20
Accepted Time:
2023-10-24 21:45:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-20 1,522 $0.00 66,355 No 4 M Direct
Common Stock Acquisiton 2023-10-21 1,145 $0.00 67,500 No 4 M Direct
Common Stock Acquisiton 2023-10-22 1,250 $0.00 68,750 No 4 M Direct
Common Stock Disposition 2023-10-23 1,565 $40.39 67,185 No 4 S Direct
Common Stock Disposition 2023-10-23 2,172 $40.37 65,013 No 4 S Direct
Common Stock Disposition 2023-10-23 203 $40.90 64,810 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2023-10-20 1,522 $0.00 1,522 $0.00
Common Stock Restricted Stock Unit Disposition 2023-10-21 1,145 $0.00 1,145 $0.00
Common Stock Restricted Stock Unit Disposition 2023-10-22 1,250 $0.00 1,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,696 No 4 M Direct
5,725 No 4 M Direct
10,000 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2022. The Reporting Person is subject to a Lock-up Letter Agreement that expires on November 5, 2023. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.80 to $40.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.81 to $40.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
  7. The RSUs vest over four years. 25% of the RSUs vest on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
  8. The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
  9. The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.